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(5.0%), normal sinus rhythm 208 times (38.4%). Interference wave of 131 times
(24.2%). (4) ILR patients during the follow-up period 17 cases (68%)with symp-
toms,13cases(52%) recorded to meaningful ECG was clear cause. 5 patients were
asymptomatic but records into meaningful ECG was diagnosed. 18 patients(72%) with
cardiac arrhythmias. (5) 18 cases of arrhythmia events recorded in patients by ILR, 2
cases not willing to once again ablation of atrial ﬂutter, 5 cases of atrial tachycardia
and 1 cases ventricular tachycardia in patients with antiarrhythmic drug therapy. 1
cases of before AF ablation with syncope symptom and paroxysmal atrial ﬁbrillation,
syncope again after ablation, ILR recorded syncope cause by ventricular tachycardia.
4 patients in sinus Beckoning bradycardia patients. After ablation of atrial ﬁbrillation
in 4 patients with atrial ﬁbrillation, 1 cases of recurrent AFL patient underwent
radiofrequency ablation. By the ILR, the 4 cases can be used to monitor the burden of
atrial ﬁbrillation in primary ablation: 25.711.4%, 23.97.5%, 19.15.6%,
18.73.2%.
Conclusions: ILR has the advantages of efﬁcient, safe, durable, high intelligence,
information can be stored. Model ILR can be obtained from the burden of atrial
ﬁbrillation, ventricular rate during atrial ﬁbrillation, the diurnal average heart rate,
heart rate variability and trends in activity. It provide objective basis for clinical
judgment, ablation of atrial ﬁbrillation occurred recurrence rate and other cardiac
events, and help for the reasonable application of anticoagulative drugs, help to reduce
the risk of ischemic and hemorrhagic events; anti arrhythmic drugs or radio frequency
ablation again provide reasonable and effective therapy.
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Combining use of Amiodarone and Esmolol In Management of Patients with
Ventricular Electrical Storm
He Yiping, Guo Hangyuan
Shaoxing People’s Hospital
Objectives: To analyze the management of ventricular electrical storm with amio-
darone and esmolol.
Methods: We conducted a retrospective analysis during last 5 years in our hospital.
To review and assess the causes, differential diagnosis and treatment with ventricular
electrical storm (VES). VES was deﬁned by 2 or more sustained episodes of ven-
tricular tachycardia or ventricular ﬁbrillation within 24 hours. All patients were treated
with electrical conversion or deﬁbrillation emergently, and treated with amiodarone, if
ineffective esmolol would be used.
Results: A total of 15 cases of ventricular electrical storm (ES) were included. Causes
of ventricular ES included: coronary atherosclerotic heart disease (n¼7), Brugada
syndrome (n¼1), Dilated cardiomyopathy (n¼3), Acute myocarditis (n¼1), Aconitine
poisoning (n¼1), Idiopathic ventricular tachycardia (n¼2). All patients were treated
with electrical conversion or deﬁbrillation emergently with averagely 4.5 times. All
cases were received intravenous injection of amiodarone,5 cases were effective ( the
effective rate was 33%).10 cases were resistant to amiodarone, and 7 cases were
successful managed by intravenous injection of esmolol (the effective rate was 70%).
3 cases were died within 24 hours, 12 cases were treated successfully (the total
effective rate of amiodarone and esmolol was 80%),After the ventricular ES subsided,
3 cases accepted ICD implantation, All 12 cases treated with amiodarone and betaloc
oral maintenance. 1 case died suddenly during a half year follow-up, None of VES
recurrence were monitored among the others.
Conclusions: Combining use of amiodarone and esmolol is effective in management
of patients with ventricular electrical storm, the early use of beta-blocking agent
especially esmolol should be considered.
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Objectives: Atrial ﬁbrillation (AF) is the most frequent arrhythmia seen in clinical
practice. Antiarrhythmic drug (AAD) has a modest long-term efﬁcacy and the po-
tential for serious side effects. Catheter ablation (CA) is now considered as a viable
alternative to AAD in maintaining sinus rhythm in patients with AF. Numerous
systematic reviews (SRs) comparing CA with AAD for AF have already been pub-
lished. Then, it is necessary and important to summarise the results of these SRs in an
overview. To conduct an overview of SRs that evaluates the efﬁcacy and safety of CA
comparing with AAD for patients with AF.
Methods: We searched the Cochrane Library, PubMed, EMBASE, Web of Science
and Chinese databases (CBM, CNKI and Wanfang) electronically and also retrieved
papers from other sources, such as searching the reference lists of all included reviews
and carrying out a citation search of those papers which cited studies included in the
review. All relevant SRs were collected to compare CA with AAD for the mainte-
nance of sinus rhythm in patients with AF. There were no language restrictions, and
we did not restrict inclusion by the kinds of CA or AAD. Two investigators inde-
pendently screened studies, extracted data and assessed the methodological quality
according to appropriate criteria. Then all of these results were checked by a third
investigator. We conducted this overview of SRs by descriptive analysis.
Results: We identiﬁed seventeen SRs for inclusion within this overview altogether,
including one Cochrane reviews and sixteen non-Cochrane reviews. One paper was
published in Chinese and the others in English. Most of the included SRs have eligibleC166 JACC Vol 64/16/Suppl C j October 16–1methodological quality. A non-Cochrane systematic review showed similar survival of
patients with AF undergoing CA compared with AAD after 12 months of follow-up,
and with no difference in the rates of stroke or transient ischemic attack. Synthesized
results of other sixteen SRs demonstrated that CA is superior to AAD for patients with
paroxysmal or persistent AF, which was associated with higher efﬁcacy rates and a
lower rate of serious complications. Additionally, three SRs performed the economic
evaluation compared between CA and AAD, and the synthesized analysis indicated
that compared to the AAD strategy, CA had a higher costs with better effectiveness.
Conclusions: Evidence from the present SRs suggest that CA may be a better treat-
ment option compared to AAD in the management of AF. We can consider CA as a
relatively effective and well-tolerated procedure for maintaining sinus rhythm.
However, the comparison of long-term efﬁcacy and safety between CA and AAD, as
well as economic variable, should be further evaluated by more large sample and high
quality studies. Ongoing clinical trials in the future may provide further information
for guidance on these treatment options for AF.
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Radiofrequency catheter ablation Of right atrioventricular accessory pathway
via unconventional left subclavian veinous access
Zhang Yonghua, Xi Su, Jinglin Zhang
Wuhan Asia Heart Hospital
Objectives: To prove the effectiveness of radiofrequency catheter ablation (RFCA) of
right atrioventricular accessory pathway Via Left subclavian veinous Access.
Methods: 22 patients [14 men average age of (41.23.7) years old] underwent
conventional electrophysiological study and diagnostic Right Atrioventricular acces-
sory pathway, but unsuccessfully RFCA via femoral vein access. Try to RFCA via
unconventional left subclavian veinous access.
Results: The right atrioventricular accessory pathway were successfully eliminated by
RFCA in all 22 cases during operation. The sites of the accessory pathway were from
the right anterior septum in 3, the right free wall in 11, the right posterolater in 8 cases.
After ablation, no patient had recurrence. The success rate was 100%.
Conclusions: The anatomy of right atrioventricular accessory pathway is compara-
tively special. Occasionally, it is difﬁcult to RFCA via femoral vein access. It’s
suggested that RFCA of right atrioventricular accessory pathway by unconventional
left subclavian veinous access may be an alternative approach.
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Objectives: To explore the changes of serum levels of CARP, hs-CRP in patients with
atrial ﬁbrillation and its signiﬁcance, and survey the relationship among CARP, hs-
CRP and cardiac function.
Methods: 124 patients of our department were divided into atrial ﬁbrillation group
(n¼64) and sinusrhythm group (n¼60) according to ECG. The two groups were
divided into three subgroups (the NYHA class I, the NYHA class II and the NYHA
class III) according to the NYHA cardiac function class. On the second morning,
Serum CARP levels in all patients were measured by enzyme-linked immune sorbent
assay (ELISA), and serum hs-CRP levels were measured by latex enhance immune
and turbidimetric immunoassay (PETIA).Then the levels of them were dealed with
statistical analysis.
Results: (1) The levels of serum CARP, hs-CRP in atrial ﬁbrillation group were
signiﬁcantly higher than those in sinus rhythm group (P<0.05).In the same NYHA
class subgroup, the levels of serum CARP, hs-CRP in atrial ﬁbrillation group were
signiﬁcantly higher than those in sinus rhythm group (P<0.05). (2) The levels of
serum CARP, hs-CRP both in atrial ﬁbrillation group and in sinus rhythm group were
in sequence increased signiﬁcantly with the NYHA class (P<0.05).
Conclusions: (1) The levels of serum CARP, hsCRP in atrial ﬁbrillation group were
signiﬁcantly higher than those in sinus rhythm group. The levels of serum CARP and
hsCRP were signiﬁcantly increased with the deterioration of cardiac function. (2)
CARP and hsCRP may be involved in the occurrence and sustainment of atrial
ﬁbrillation. The levels of serum CARP, hsCRP may serve as an independent index of
atrial ﬁbrillation.
GW25-e4526
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Objectives: To compare the efﬁcacy and safety of pulmonary vein isolation (PVI)
versus PVI plus adjunctive ablation of complex fractionated atrial electrograms
(CFAEs) in patients with atrial ﬁbrillation (AF) after a single procedure.
Methods: Literature search was conducted in PubMed, EMBASE, Cochrane Library,
CBM, Elsevier, CNKI and VIP for the clinical controlled trials of PVI versus PVI plus
adjunctive ablation of CFAEs in patients with AF, from January 1, 1980 to August 31,9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
